Clinical trial
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
NCT00455923 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00455923 |
|---|---|
| Title | SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII) |
| Official title | SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Seretide, Flixotide |
| Enrollment | 100 |
| Start date | May 3, 2005 |
| Primary completion | Jul 31, 2007 |
| Completion | Jul 31, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Feb 5, 2018 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: